Literature DB >> 16007071

Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype.

Costanza Ballarò1, Sara Ceccarelli, Cecilia Tiveron, Laura Tatangelo, Anna Maria Salvatore, Oreste Segatto, Stefano Alemà.   

Abstract

Although it has been clearly established that negative feedback loops have a fundamental role in the regulation of epidermal growth factor receptor (EGFR) signalling in flies, their role in the regulation of mammalian EGFR has been inferred only recently from in vitro studies. Here, we report on the forced expression of RALT/MIG-6, a negative feedback regulator of ErbB receptors, in mouse skin. A RALT transgene driven by the K14 promoter generated a dose-dependent phenotype resembling that caused by hypomorphic and antimorphic Egfr alleles-that is, wavy coat, curly whiskers and open eyes at birth. Ex vivo keratinocytes from K14-RALT mice showed reduced biochemical and biological responses when stimulated by ErbB ligands. Conversely, knockdown of RALT by RNA interference enhanced ErbB mitogenic signalling. Thus, RALT behaves as a suppressor of EGFR signalling in mouse skin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007071      PMCID: PMC1369136          DOI: 10.1038/sj.embor.7400458

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  22 in total

Review 1.  Negative regulation of receptor tyrosine kinase signals.

Authors:  M Fiorini; M Alimandi; L Fiorentino; G Sala; O Segatto
Journal:  FEBS Lett       Date:  2001-02-16       Impact factor: 4.124

Review 2.  Endocytosis and signaling. an inseparable partnership.

Authors:  P P Di Fiore; P De Camilli
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

3.  Mig-6 is a negative regulator of the epidermal growth factor receptor signal.

Authors:  P O Hackel; M Gishizky; A Ullrich
Journal:  Biol Chem       Date:  2001-12       Impact factor: 3.915

4.  Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.

Authors:  J Albanell; J Codony-Servat; F Rojo; J M Del Campo; S Sauleda; J Anido; G Raspall; J Giralt; J Roselló; R I Nicholson; J Mendelsohn; J Baselga
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

5.  Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

Authors:  S W Stoll; S Kansra; S Peshick; D W Fry; W R Leopold; J F Wiesen; M Sibilia; T Zhang; Z Werb; R Derynck; E F Wagner; J T Elder
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

6.  Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain.

Authors:  L Fiorentino; C Pertica; M Fiorini; C Talora; M Crescenzi; L Castellani; S Alemà; P Benedetti; O Segatto
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  In vivo introduction of the interleukin 6 gene into human keratinocytes: induction of epidermal proliferation by the fully spliced form of interleukin 6, but not by the alternatively spliced form.

Authors:  M Sato; D Sawamura; S Ina; T Yaguchi; K Hanada; I Hashimoto
Journal:  Arch Dermatol Res       Date:  1999 Jul-Aug       Impact factor: 3.017

8.  Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control.

Authors:  Monia Fiorini; Costanza Ballarò; Gianluca Sala; Germana Falcone; Stefano Alemà; Oreste Segatto
Journal:  Oncogene       Date:  2002-09-19       Impact factor: 9.867

9.  c-Jun regulates eyelid closure and skin tumor development through EGFR signaling.

Authors:  Rainer Zenz; Harald Scheuch; Paul Martin; Carsten Frank; Robert Eferl; Lukas Kenner; Maria Sibilia; Erwin F Wagner
Journal:  Dev Cell       Date:  2003-06       Impact factor: 12.270

10.  A tumor-associated beta 1 integrin mutation that abrogates epithelial differentiation control.

Authors:  Richard D Evans; Vivienne C Perkins; Alistair Henry; Paul E Stephens; Martyn K Robinson; Fiona M Watt
Journal:  J Cell Biol       Date:  2003-02-10       Impact factor: 10.539

View more
  20 in total

1.  Gene 33/RALT is induced by hypoxia in cardiomyocytes, where it promotes cell death by suppressing phosphatidylinositol 3-kinase and extracellular signal-regulated kinase survival signaling.

Authors:  Dazhong Xu; Richard D Patten; Thomas Force; John M Kyriakis
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 2.  New Horizons for Precision Medicine in Biliary Tract Cancers.

Authors:  Juan W Valle; Angela Lamarca; Lipika Goyal; Jorge Barriuso; Andrew X Zhu
Journal:  Cancer Discov       Date:  2017-08-17       Impact factor: 39.397

3.  TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation.

Authors:  Xiping Cheng; Jie Jin; Lily Hu; Dongbiao Shen; Xian-Ping Dong; Mohammad A Samie; Jayne Knoff; Brian Eisinger; Mei-Ling Liu; Susan M Huang; Michael J Caterina; Peter Dempsey; Lowell Evan Michael; Andrzej A Dlugosz; Nancy C Andrews; David E Clapham; Haoxing Xu
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

4.  A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation.

Authors:  Yuri Frosi; Sergio Anastasi; Costanza Ballarò; Giulia Varsano; Loriana Castellani; Elena Maspero; Simona Polo; Stefano Alemà; Oreste Segatto
Journal:  J Cell Biol       Date:  2010-04-26       Impact factor: 10.539

5.  Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.

Authors:  Christopher G Duncan; Patrick J Killela; Cathy A Payne; Benjamin Lampson; William C Chen; Jeff Liu; David Solomon; Todd Waldman; Aaron J Towers; Simon G Gregory; Kerrie L McDonald; Roger E McLendon; Darell D Bigner; Hai Yan
Journal:  Oncotarget       Date:  2010-08

6.  Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.

Authors:  Nili Jin; Sung-Nam Cho; M Gabriela Raso; Ignacio Wistuba; Yvonne Smith; Yanan Yang; Jonathan M Kurie; Rudolph Yen; Christopher M Evans; Thomas Ludwig; Jae-Wook Jeong; Francesco J DeMayo
Journal:  Development       Date:  2009-08-26       Impact factor: 6.868

Review 7.  The ErbB kinase domain: structural perspectives into kinase activation and inhibition.

Authors:  Ron Bose; Xuewu Zhang
Journal:  Exp Cell Res       Date:  2008-08-15       Impact factor: 3.905

Review 8.  Mechanisms of ErbB receptor negative regulation and relevance in cancer.

Authors:  William H D Fry; Lakmal Kotelawala; Colleen Sweeney; Kermit L Carraway
Journal:  Exp Cell Res       Date:  2008-07-31       Impact factor: 3.905

9.  Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis.

Authors:  Ann M Bode; Yong-Yeon Cho; Duo Zheng; Feng Zhu; Marna E Ericson; Wei-Ya Ma; Ke Yao; Zigang Dong
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

10.  Epidermal stem cell diversity and quiescence.

Authors:  Fiona M Watt; Kim B Jensen
Journal:  EMBO Mol Med       Date:  2009-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.